CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
BioMarin Pharmaceutical (BMRN.O) is an international producer of innovative biopharmaceuticals for rare genetic diseases. The company’s developments provide significant advances for patients with rare, life-threatening diagnoses. BioMarin introduces new treatments to the market, providing enormous help to adults and children with serious inherited conditions that have few treatment options. Lately, the company has been named as one of the fastest developers of medicines.
The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.
14:43, 2 February 2024
Read our reviews to find out more about us
Read the feedback from our clients, whatever their experience level.
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.